在肝细胞癌的碳离子放射治疗后使用数据采集方法进行预后风险分类的新方法
Kazuhiko Hayashi1,2, Osamu Suzuki1, Koji Ichise1
1Department of Radiology, Osaka Heavy Ion Therapy Center, Osaka, Japan.
Cancer science
|May 25, 2025
概括
这项研究开发了一种新的癌症特异性存活率 (CSS) 的风险分类,用于肝细胞癌的碳离子放射治疗. 决策树分析确定了关键因素,使分层成为低风险,中等风险和高风险群体.
科学领域:
- 在瘤学瘤学.
- 辐射疗法 辐射疗法
- 数据挖掘 数据挖掘
背景情况:
- 肝细胞癌 (HCC) 治疗缺乏碳离子放射治疗的既定预后模型.
- 预测癌症特异性存活率 (CSS) 对于优化患者管理至关重要.
研究的目的:
- 在HCC患者进行碳离子放射治疗后开发CSS的风险分类系统.
- 使用决策树分析 (DTA) 识别显著的预后因素.
主要方法:
- 对90名接受碳离子放射治疗的HCC患者 (2018-2022) 的回顾性分析.
- 使用单变量,多变量分析和DTA来确定CSS和无进展生存期 (PFS) 的预后因素.
- 辐射剂量标准为60 Gy (相对生物有效性 (RBE)),根据瘤与胃肠道的近距离而变化分成.
主要成果:
- 多变量分析确定了剂量分成和预处理的α-fetoprotein水平作为PFS和CSS的显著预后因素.
- 临床阶段和因维生素K缺乏或对手II值引起的预治疗蛋白质是CSS的显著预后因素.
- DTA成功地将患者分为低风险 (100% 3年CSS),中等风险 (73.3% 3年CSS) 和高风险 (44.4% 3年CSS) 组.
结论:
- 决策树分析为接受碳离子放射治疗的HCC患者的风险分层提供了一种新方法.
- 基于瘤标志物和临床阶段的开发分类系统可以帮助预测CSS.
- 这种方法为个性化治疗策略和改善患者治疗结果提供了基础.
更多相关视频
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
202
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
6.9K
相关概念视频
01:21Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
01:24Kaplan-Meier Approach
284
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
284